Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Regulatory News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Jun 2023 13:35

RNS Number : 4207E
Advanced Oncotherapy PLC
29 June 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BD6SX109

Issuer Name

ADVANCED ONCOTHERAPY PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

ODEY ASSET MANAGEMENT LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

28-Jun-2023

6. Date on which Issuer notified

29-Jun-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

7.490000

10.630000

18.120000

97973508

Position of previous notification (if applicable)

9.140000

10.680000

19.820000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BD6SX109

40473508

0

7.490000

0.000000

Sub Total 8.A

40473508

7.490000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Warrant

1 July 2026

Cash

18000000

3.330000

Warrant

30 march 2026

Cash

8000000

1.480000

Warrant

31 OCTOBER 2027

Cash

24000000

4.440000

Warrant

25 February 2025

Cash

7500000

1.390000

Sub Total 8.B2

57500000

10.630000%

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

none

12. Date of Completion

29-Jun-2023

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKOUROOUNUAR
Date   Source Headline
11th Oct 201611:37 amRNSHolding(s) in Company
11th Oct 201610:54 amRNSHolding(s) in Company
10th Oct 201611:44 amRNSDirectorate Change
30th Sep 20167:45 amRNSSubscription and Proposed Open Offer
30th Sep 20167:00 amRNSHalf-year Report
6th Sep 20167:00 amRNSAppointment of Director of Medical Physics
4th Aug 20165:05 pmRNSHolding(s) in Company
4th Aug 20168:13 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSExercise of warrants
19th Jul 201611:27 amRNSHolding(s) in Company
19th Jul 201611:24 amRNSHolding(s) in Company
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
11th Jul 201610:06 amRNSDirector/PDMR Shareholding
8th Jul 20167:00 amRNSDirector/PDMR Shareholding
7th Jul 20166:01 pmRNSDirector/PDMR Shareholding
30th Jun 20164:19 pmRNSResult of AGM and share consolidation
22nd Jun 20167:00 amRNSAGM Presentation
7th Jun 20167:00 amRNSExercise of options and issue of shares
31st May 20167:00 amRNSFinal Results
26th May 20167:00 amRNS£24m financing secured for Harley Street
12th May 20164:02 pmRNSHolding(s) in Company
3rd May 20169:01 amRNSUpdate on Harley Street
18th Apr 20167:00 amRNSExercise of warrants and issue of shares
29th Mar 20167:00 amRNSUpdate on development milestones
1st Mar 20167:00 amRNSSenior Management Appointments
22nd Feb 20165:02 pmRNSHolding(s) in Company
8th Feb 20167:01 amRNSDirectorate Change
8th Feb 20167:00 amRNSThales industrialisation agreement
4th Feb 201612:35 pmRNSNomad change of name
21st Dec 20157:00 amRNSDirectors' Dealing
18th Dec 20152:42 pmRNSDirector Dealing
17th Dec 20159:40 amRNSDirector Dealing
24th Nov 20158:06 amRNSAppointment of Executive Chairman at ADAM
18th Nov 20157:00 amRNSDisposal of ORL
16th Nov 20157:00 amRNSSuccessful high power testing of CCL modules
21st Oct 20157:00 amRNSSecond commercial sale of proton therapy system
12th Oct 20157:00 amRNSOperator agreement with CircleHealth for Harley St
12th Oct 20157:00 amRNSStatement regarding new cancer centre
22nd Sep 20157:00 amRNSHalf Yearly Report
21st Sep 20153:31 pmRNSNotice of Results
21st Sep 20157:00 amRNSFirst milestone payment for China LIGHT system
3rd Sep 20159:34 amRNSChange of Registered Office & Trading address
24th Aug 20157:00 amRNSCCL modules ready for high-power testing
20th Aug 20157:00 amRNSSinophi agreement with Jilin University
10th Aug 201511:16 amRNSHolding(s) in Company
31st Jul 20157:00 amRNSExercise of warrants and options & issue of shares
29th Jul 20157:00 amRNSExercise of warrants and issue of shares
28th Jul 20157:00 amRNSDelivery of additional CCL unit & Harley St update
20th Jul 20153:10 pmRNSReplacement: Director Dealing and Award of Options
20th Jul 20157:00 amRNSDirector Dealing and Award of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.